Compare
2 stocks, side by sideRelative performance · rebased to 100
GMABINCY
Pair ratio · GMAB ÷ INCYRelative value, rich or cheap vs their own history
The price ratio GMAB ÷ INCY with its 1Y mean and ±1σ / ±2σ bands; the z-score is how far the ratio sits from its average. A stretched reading flags one stock as rich vs the other relative to their history, but mean-reversion isn't guaranteed (a durable re-rating from better growth or margins can keep the ratio elevated). Research tooling, not advice.
| GMABGenmab A/S | INCYIncyte | |
|---|---|---|
| Smart Score | 9/10 | 10/10 |
| Price | $26.14 | $108.46 |
| 1 month | -2.8% | +12% |
| 1 year | +26% | +61% |
| 5 year | -40% | +30% |
| P/E (TTM) | 19.5 | 14.9 |
| P/E vs sector | -38% | - |
| Market cap | $16.0B | $19.6B |
| Sector | Healthcare | Health Care |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.